Liver Cirrhosis, Biliary D008105

Related MeSH Hierarchy (4)

Diseases [C] » Digestive System Diseases [C06] » Biliary Tract Diseases » Bile Duct Diseases » Cholestasis » Cholestasis, Intrahepatic » Liver Cirrhosis, Biliary

Diseases [C] » Digestive System Diseases [C06] » Liver Diseases » Cholestasis, Intrahepatic » Liver Cirrhosis, Biliary

Diseases [C] » Digestive System Diseases [C06] » Liver Diseases » Liver Cirrhosis » Liver Cirrhosis, Biliary

Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Fibrosis » Liver Cirrhosis » Liver Cirrhosis, Biliary

Description

FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.   MeSH

Approved Indicated Drugs (2)

Phase 4 Indicated Drugs (2)

Other Experimental Indicated Drugs (2)


Organization Involved with Other Experimental Indications (3)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.